MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517051567 A) filed by Petra Pharma Corporation, Indianapolis, on May 29, for 'allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease.'
Inventor(s) include Dawadi, Surendra; Wang, Hua-Yu; Sainz, Marcos Adrian; Kolakowski, Gabrielle R; Wright, Edward Nathan; Mayne, Christopher Glenn; Pototschnig, Gerit Maria; Anderson, Erin; Chan, Warren Christopher; Chen, Shuai; Kumar, Manoj; Lee, Kyunga; Murhade, Ganesh; Salib, Mariam Nader; Scaggs, Latoya Denise; Wang, Xia; Irvin, Thomas; Picado Valenzuela, Alfredo; Long, Katelyn; and Jette, Carina.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I): (I) or pharmaceutically acceptable salts thereof wherein R1, R2, R3, R4, R5, R6, R7, and R8, are as defined herein. The disclosure also relates to methods of making and using compounds of Formula (I) or pharmaceutically acceptable salts thereof."
The patent application was internationally filed on Oct. 31, 2023, under International application No.PCT/US2023/036386.
Disclaimer: Curated by HT Syndication.
